Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug tested to help dialysis patients fight anemia

NCT ID NCT03439137

Completed Disease control Sponsor: Tanabe Pharma Corporation Source: ClinicalTrials.gov ↗

Summary

This study tested if a new drug called MT-6548 works as well as a standard treatment (darbepoetin alfa) for anemia in people with chronic kidney disease who are on dialysis. It involved 323 participants in Japan who were already receiving treatment for their anemia. The main goal was to see if the new drug could keep hemoglobin levels stable and to check its long-term safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research site

    Aichi, Japan

  • Research site

    Chiba, Japan

  • Research site

    Fukui, Japan

  • Research site

    Fukuoka, Japan

  • Research site

    Fukushima, Japan

  • Research site

    Gunma, Japan

  • Research site

    Hiroshima, Japan

  • Research site

    Hokkaido, Japan

  • Research site

    Hyōgo, Japan

  • Research site

    Ibaraki, Japan

  • Research site

    Kagawa, Japan

  • Research site

    Kagoshima, Japan

  • Research site

    Kanagawa, Japan

  • Research site

    Kumamoto, Japan

  • Research site

    Kyoto, Japan

  • Research site

    Miyagi, Japan

  • Research site

    Nagano, Japan

  • Research site

    Nagasaki, Japan

  • Research site

    Okayama, Japan

  • Research site

    Okinawa, Japan

  • Research site

    Osaka, Japan

  • Research site

    Ōita, Japan

  • Research site

    Saitama, Japan

  • Research site

    Shiga, Japan

  • Research site

    Shizuoka, Japan

  • Research site

    Tokushma, Japan

  • Research site

    Tokyo, Japan

  • Research site

    Yamagata, Japan

Conditions

Explore the condition pages connected to this study.

ANEMIA; HEMODIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE